AGS 2021
    Glaucoma, Surgical Management

    In this interview from AGS 2021, Dr. Davinder Grover discusses early outcomes with the Ahmed ClearPath device. The shunt showed a good safety and efficacy profile in a 100-patient study at 6 months. There were no differences between safety or efficacy differences between the 250 mm2 and 350 mm2 plate sizes.

    Relevant Financial Disclosures: Dr. Grover is a consultant for and receives lecturing fees from New World Medical.